Subscribe to RSS
DOI: 10.1055/s-0031-1273325
© Georg Thieme Verlag KG Stuttgart · New York
Diagnose und Therapie der Skleritis bei entzündlichen Systemerkrankungen
Diagnosis and Treatment of Scleritis Associated to Inflammatory Systemic DiseasesPublication History
Eingegangen: 1.1.2011
Angenommen: 21.3.2011
Publication Date:
29 April 2011 (online)

Zusammenfassung
Aufgrund potenziell visusbedrohender Komplikationen und der Assoziation zu Systemerkrankungen mit einer erhöhten Mortalität sind bei Skleritiden eine gezielte Diagnostik und eine frühzeitige und aggressive entzündungshemmende Systemtherapie notwendig. Neue therapeutische Optionen (wie z. B. Biologica) können in ansonsten therapieresistenten Fällen eine Remission erzielen.
Abstract
Because of potential vision-threatening complications and the association to inflammatory systemic diseases with an increased mortality, scleritis patients need an adequate diagnostic work-up and early and aggressive anti-inflammatory systemic treatment. New therapeutic options (such as biologicals) help to achieve remission in otherwise refractory cases.
Schlüsselwörter
Skleritis - Diagnose - Therapie
Key words
scleritis - diagnosis - treatment
Literatur
- 1
Okhravi N, Odufuwa B, McCluskey P et al.
Scleritis.
Surv Ophthalmol.
2005;
50
351-363
MissingFormLabel
- 2
Sainz de la Maza M, Jabbur N S, Foster C S.
Severity of scleritis and episcleritis.
Ophthalmology.
1994;
101
389-396
MissingFormLabel
- 3
Jabs D A, Rosenbaum J T, Foster C S et al.
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory
disorders: recommendations of an expert panel.
Am J Ophthalmol.
2000;
130
492-513
MissingFormLabel
- 4
Albini T A, Rao N A, Smith R E.
The diagnosis and management of anterior scleritis.
Int Ophthalmol Clin.
2005;
45
191-204
MissingFormLabel
- 5
Rachitskaya A, Mandelcorn E D, Albini T A.
An update on the cause and treatment of scleritis.
Curr Opin Ophthalmol.
2010;
21
463-467
MissingFormLabel
- 6
Sainz de la Maza M, Foster C S, Jabbur N S.
Scleritis associated with systemic vasculitic diseases.
Ophthalmology.
1995;
102
687-692
MissingFormLabel
- 7
Raiji V R, Palestine A G, Parver D L.
Scleritis and systemic disease association in a community-based referral practice.
Am J Ophthalmol.
2009;
148
946-950
MissingFormLabel
- 8
Afshari N A, Afshari M A, Foster C S.
Inflammatory conditions of the eye associated with rheumatic diseases.
Curr Rheumatol Rep.
2001;
3
453-458
MissingFormLabel
- 9
Bullen C L, Liesegang T J, McDonald T J et al.
Ocular complications of Wegener’s granulomatosis.
Ophthalmology.
1983;
90
279-290
MissingFormLabel
- 10
Isaak B L, Liesegang T J, Michet Jr C J.
Ocular and systemic findings in relapsing polychondritis.
Ophthalmology.
1986;
93
681-689
MissingFormLabel
- 11
Tuft S J, Watson P G.
Progression of scleral disease.
Ophthalmology.
1991;
98
467-471
MissingFormLabel
- 12
Foster C S.
Immunosuppressive therapy for external ocular inflammatory disease.
Ophthalmology.
1980;
87
140-150
MissingFormLabel
- 13
Watson P G, Hayreh S S.
Scleritis and episcleritis.
Br J Ophthalmol.
1976;
60
163-191
MissingFormLabel
- 14
Rao N A, Marak G E, Hidayat A A.
Necrotizing scleritis. A clinico-pathologic study of 41 cases.
Ophthalmology.
1985;
92
1542-1549
MissingFormLabel
- 15
Hemady R, Sainz de la Maza M, Raizman M B et al.
Six cases of scleritis associated with systemic infection.
Am J Ophthalmol.
1992;
114
55-62
MissingFormLabel
- 16
Feiz V, Redline D E.
Infectious scleritis after pars plana vitrectomy because of methicillin-resistant
Staphylococcus aureus resistant to fourth-generation fluoroquinolones.
Cornea.
2007;
26
238-240
MissingFormLabel
- 17
Howell A, Midturi J, Sierra-Hoffman M et al.
Aspergillus flavus scleritis: successful treatment with voriconazole and caspofungin.
Med Mycol.
2005;
43
651-655
MissingFormLabel
- 18
Huang F C, Huang S P, Tseng S H.
Management of infectious scleritis after pterygium excision.
Cornea.
2000;
19
34-39
MissingFormLabel
- 19
Hwang Y S, Chen Y F, Lai C C et al.
Infectious scleritis after use of immunomodulators.
Arch Ophthalmol.
2002;
120
1093-1094
MissingFormLabel
- 20
Meyer J J, Espandar L, Marx D P et al.
Pseudomonas scleritis resistant to fourth-generation fluoroquinolones in a patient
without prior trauma or surgery.
Ocul Immunol Inflamm.
2008;
16
127-129
MissingFormLabel
- 21
Moreno Honrado M, del Campo Z, Buil J A.
A case of necrotizing scleritis resulting from Pseudomonas aeruginosa.
Cornea.
2009;
28
1065-1066
MissingFormLabel
- 22
Rich R M, Smiddy W E, Davis J L.
Infectious scleritis after retinal surgery.
Am J Ophthalmol.
2008;
145
695-699
MissingFormLabel
- 23
Seth R K, Gaudio P A.
Nocardia asteroides necrotizing scleritis associated with subtenon triamcinolone acetonide
injection.
Ocul Immunol Inflamm.
2008;
16
139-140
MissingFormLabel
- 24
Bhat P V, Jakobiec F A, Kurbanyan K et al.
Chronic herpes simplex scleritis: characterization of 9 cases of an underrecognized
clinical entity.
Am J Ophthalmol.
2009;
148
779-789
MissingFormLabel
- 25
Jain V, Shome D, Natarajan S et al.
Surgically induced necrotizing scleritis after pterygium surgery with conjunctival
autograft.
Cornea.
2008;
27
720-721
MissingFormLabel
- 26
Morley A MS, Pavesio C.
Surgically induced necrotising scleritis following three-port pars plana vitrectomy
without scleral buckling: a series of three cases.
Eye.
2008;
22
162-164
MissingFormLabel
- 27
Nguyen D Q, Raman V S, Twomey J M et al.
Keratectasia as a presentation of surgically induced necrotizing sclerokeratitis (SINS).
Eye Contact Lens.
2007;
33
332-333
MissingFormLabel
- 28
Sainz de la Maza M, Foster C S.
Necrotizing scleritis after ocular surgery. A clinicopathologic study.
Ophthalmology.
1991;
98
1720-1726
MissingFormLabel
- 29
Salacz G.
Postoperative necrotizing sclerokeratitis.
Doc Ophthalmol.
1992;
80
167-170
MissingFormLabel
- 30
O’Donoghue E, Lightman S, Tuft S et al.
Surgically induced necrotising sclerokeratitis (SINS) – precipitating factors and
response to treatment.
Br J Ophthalmol.
1992;
76
17-21
MissingFormLabel
- 31
McCluskey P J, Watson P G, Lightman S et al.
Posterior scleritis: clinical features, systemic associations, and outcome in a large
series of patients.
Ophthalmology.
1999;
106
2380-2386
MissingFormLabel
- 32
Sen H N, Sangave A, Hammel K et al.
Infliximab for the treatment of active scleritis.
Can J Ophthalmol.
2009;
44
e9-e12
MissingFormLabel
- 33
Doctor P, Sultan A, Syed S et al.
Infliximab for the treatment of refractory scleritis.
Br J Ophthalmol.
2010;
94
579-583
MissingFormLabel
- 34
Ahn S J, Oh J Y, Kim M K et al.
Treating refractory scleritis with infliximab.
Jpn J Ophthalmol.
2009;
53
286-287
MissingFormLabel
- 35
Kontkanen M, Paimela L, Kaarniranta K.
Regression of necrotizing scleritis in Wegener’s granulomatosis after infliximab treatment.
Acta Ophthalmol.
2010;
88
e96-e97
MissingFormLabel
- 36
Restrepo J P, Molina M P.
Successful treatment of severe nodular scleritis with adalimumab.
Clin Rheumatol.
2010;
29
559-561
MissingFormLabel
- 37
Kurz P A, Suhler E B, Choi D et al.
Rituximab for treatment of ocular inflammatory disease: a series of four cases.
Br J Ophthalmol.
2009;
93
546-548
MissingFormLabel
- 38
Chauhan S, Kamal A, Thompson R N et al.
Rituximab for treatment of scleritis associated with rheumatoid arthritis.
Br J Ophthalmol.
2009;
93
984-985
MissingFormLabel
- 39
Taylor S RJ, Salama A D, Joshi L et al.
Rituximab is effective in the treatment of refractory ophthalmic Wegener’s granulomatosis.
Arthritis Rheum.
2009;
60
1540-1547
MissingFormLabel
- 40
Benson W E.
Posterior scleritis.
Surv Ophthalmol.
1988;
32
297-316
MissingFormLabel
- 41
Sainz de la Maza M, Jabbur N S, Foster C S.
An analysis of therapeutic decision for scleritis.
Ophthalmology.
1993;
100
1372-1376
MissingFormLabel
- 42
Singh G, Guthoff R, Foster C S.
Observations on long-term follow-up of posterior scleritis.
Am J Ophthalmol.
1986;
101
570-575
MissingFormLabel
- 43
Calthorpe C M, Watson P G, McCartney A C.
Posterior scleritis: a clinical and histological survey.
Eye.
1988;
2 (Pt 3)
267-277
MissingFormLabel
- 44
Chaques V J, Lam S, Tessler H H et al.
Computed tomography and magnetic resonance imaging in the diagnosis of posterior scleritis.
Ann Ophthalmol.
1993;
25
89-94
MissingFormLabel
- 45
Watson P G.
Anterior segment fluorescein angiography in the surgery of immunologically induced
corneal and scleral destructive disorders.
Ophthalmology.
1987;
94
1452-1464
MissingFormLabel
- 46
Watson P G.
Doyne Memorial Lecture, 1982. The nature and the treatment of scleral inflammation.
Trans Ophthalmol Soc U K.
1982;
102 (pt 2)
257-281
MissingFormLabel
- 47
Heiligenhaus A, Schilling M, Lung E et al.
Ultrasound biomicroscopy in scleritis.
Ophthalmology.
1998;
105
527-534
MissingFormLabel
- 48
Fong L P, Sainz de la Maza M, Rice B A et al.
Immunopathology of scleritis.
Ophthalmology.
1991;
98
472-479
MissingFormLabel
- 49
Kafkala C, Daoud Y J, Paredes I et al.
Masquerade scleritis.
Ocul Immunol Inflamm.
2005;
13
479-482
MissingFormLabel
- 50
Soukiasian S H, Foster C S, Niles J L et al.
Diagnostic value of anti-neutrophil cytoplasmic antibodies in scleritis associated
with Wegener’s granulomatosis.
Ophthalmology.
1992;
99
125-132
MissingFormLabel
- 51
Jabs D A, Mudun A, Dunn J P et al.
Episcleritis and scleritis: clinical features and treatment results.
Am J Ophthalmol.
2000;
130
469-476
MissingFormLabel
- 52
Gangaputra S, Newcomb C W, Liesegang T L et al.
Methotrexate for ocular inflammatory diseases.
Ophthalmology.
2009;
116
2188-2198
MissingFormLabel
- 53
Pasadhika S, Kempen J H, Newcomb C W et al.
Azathioprine for ocular inflammatory diseases.
Am J Ophthalmol.
2009;
148
500-509
MissingFormLabel
- 54
Daniel E, Thorne J E, Newcomb C W et al.
Mycophenolate mofetil for ocular inflammation.
Am J Ophthalmol.
2010;
149
423-432
MissingFormLabel
- 55
Kaçmaz R O, Kempen J H, Newcomb C et al.
Cyclosporine for ocular inflammatory diseases.
Ophthalmology.
2010;
117
576-584
MissingFormLabel
- 56
Iaccheri B, Androudi S, Bocci E B et al.
Rituximab treatment for persistent scleritis associated with rheumatoid arthritis.
Ocul Immunol Inflamm.
2010;
18
223-225
MissingFormLabel
- 57
Albini T A, Zamir E, Read R W et al.
Evaluation of subconjunctival triamcinolone for nonnecrotizing anterior scleritis.
Ophthalmology.
2005;
112
1814-1820
MissingFormLabel
- 58
Roufas A, Jalaludin B, Gaskin C et al.
Subconjunctival triamcinolone treatment for non-necrotising anterior scleritis.
Br J Ophthalmol.
2010;
94
743-747
MissingFormLabel
- 59
Sohn E H, Wang R, Read R.
Long-term, multicenter evaluation of subconjunctival injection of triamcinolone for
nonnecrotizing, noninfectious anterior scleritis.
Ophthalmology.
(in press)
MissingFormLabel
- 60
Zamir E, Read R W, Smith R E et al.
A prospective evaluation of subconjunctival injection of triamcinolone acetonide for
resistant anterior scleritis.
Ophthalmology.
2002;
109
798-805
; discussion 805 – 797
MissingFormLabel
- 61
Jabs D A.
Discussion.
Ophthalmology.
2002;
109
806-807
MissingFormLabel
- 62
Fraunfelder F T, Watson P G.
Evaluation of eyes enucleated for scleritis.
Br J Ophthalmol.
1976;
60
227-230
MissingFormLabel
- 63
Cordero-Coma M, Franco-Benito M, García-Ruiz-de-Morales J M et al.
Successful treatment of surgically induced necrotizing sclerokeratitis (SINS) with
systemic immunosuppresive agents and amniotic membrane grafting.
Arch Soc Esp Oftalmol.
2009;
84
577-580
MissingFormLabel
- 64
Sainz de la Maza M, Tauber J, Foster C S.
Scleral grafting for necrotizing scleritis.
Ophthalmology.
1989;
96
306-310
MissingFormLabel
Dr. Christoph Tappeiner
Universitätsklinik für Augenheilkunde, Inselspital
Freiburgstr. 10
3010 Bern
Schweiz
Phone: ++ 41/31/6 32 85 03
Fax: ++ 41/31/3 82 47 79
Email: christoph.tappeiner@insel.ch